Evaluating Instructors Sitting At The TABLE (Technology Access For Better Learning And Employment)

This paper focuses on the Technology Access for Better Learning and Employment Checklist developed by the authors. This evaluation tool was created and then used to measure eight instructors’ability to use technology in their teaching in four adult programs sponsored in part by the Ohio Cooperative Extension Service and a partner, Godman Guild, a settlement house located in a Columbus, Ohio neighborhood identified as located in an empowerment zone. Funding through the Federal Department of Education for a Community Technology Center was granted for this project which required an instructor pre and post evaluation component to be conducted by the Center on Education and Training for Employment. The data collected using this instrument was then used to design customized professional development plans and interventions to address technology usage as well as general instructional competencies for effective adult teaching for learning. The contribution of this paper is the TABLE Checklist and professional development system designed for this project

Targeted Strategies for Henipavirus Therapeutics

Hendra and Nipah viruses are related emergent paramyxoviruses that infect and cause disease in animals and humans. Disease manifests as a generalized vasculitis affecting multiple organs, but is the most severe in the respiratory and central nervous systems. The high case fatality and person-to-person transmission associated with the most recent NiV outbreaks, and the recent re-emergence of HeV, emphasize the importance and necessity of effective therapeutics for these novel agents. In recent years henipavirus research has revealed a more complete understanding of pathogenesis and, as a consequence, viable approaches towards vaccines and therapeutics have emerged. All strategies target early steps in viral replication including receptor binding and membrane fusion. Animal models have been developed, some of which may prove more valuable than others for evaluating the efficacy of therapeutic agents and regimes. Assessments of protective host immunity and drug pharmacokinetics will be crucial to the further advancement of therapeutic compounds

Effects of Barnacle Encrustation on the Swimming Behaviour, Energetics, Morphometry, and Drag Coefficient of the Scallop Chlamys Hastata

Barnacle encrustation negatively influenced every aspect of swimming in the scallop Chlamys hastata measured in this study. Scallops swam significantly longer, travelled further and attained greater elevation once epibiotic barnacles had been removed. Shell morphometry of barnacle-encrusted scallops was similar to shells of unencrusted scallops. Specifically, shell length was positively allometric with shell height and shell mass was negatively allometric. However, adductor muscle mass scaled isometrically to shell height, in contrast to unencrusted scallops. In the laboratory, the drag coefficient (Cd) of barnacle-encrusted scallops decreased after barnacle removal, in contrast to sponge-encrusted scallops in which no decrease in Cd was detected when the sponge was removed from the scallop\u27s valves. Furthermore, scallops swimming with barnacle encrustation required more energy than did unencrusted scallops. Although there was no significant difference in aerobic energy expenditure between swimming barnacle-encrusted and unencrusted scallops, differences in anaerobic energy expenditure were detected. Specifically, barnacle-encrusted scallops required more arginine phosphate than unencrusted scallops to swim to exhaustion although octopine levels were similar. Thus, barnacle encrustation dramatically decreased a scallop\u27s ability to swim, partly by increasing the drag coefficient experienced by the scallop and the energy required for swimming

Effects of Barnacle Encrustation on the Swimming Behaviour, Energetics, Morphometry, and Drag Coefficient of the Scallop Chlamys Hastata

Barnacle encrustation negatively influenced every aspect of swimming in the scallop Chlamys hastata measured in this study. Scallops swam significantly longer, travelled further and attained greater elevation once epibiotic barnacles had been removed. Shell morphometry of barnacle-encrusted scallops was similar to shells of unencrusted scallops. Specifically, shell length was positively allometric with shell height and shell mass was negatively allometric. However, adductor muscle mass scaled isometrically to shell height, in contrast to unencrusted scallops. In the laboratory, the drag coefficient (Cd) of barnacle-encrusted scallops decreased after barnacle removal, in contrast to sponge-encrusted scallops in which no decrease in Cd was detected when the sponge was removed from the scallop\u27s valves. Furthermore, scallops swimming with barnacle encrustation required more energy than did unencrusted scallops. Although there was no significant difference in aerobic energy expenditure between swimming barnacle-encrusted and unencrusted scallops, differences in anaerobic energy expenditure were detected. Specifically, barnacle-encrusted scallops required more arginine phosphate than unencrusted scallops to swim to exhaustion although octopine levels were similar. Thus, barnacle encrustation dramatically decreased a scallop\u27s ability to swim, partly by increasing the drag coefficient experienced by the scallop and the energy required for swimming

Effects of Sponge Encrustation on the Swimming Behaviour, Energetics and Morphometry of the Scallop Chlamys Hastata

The effect of sponge encrustation on swimming ability of Chlamys hastata was determined by investigating swimming behaviour, scallop morphometry, and energy expended during swimming with and without commensal epibionts. Scallops swam significantly longer after sponge encrustation was removed from their shells, but no significant differences were detected in swimming elevation or distance. Scallops with sponge encrustation showed no adductor muscle hypertrophy or changes in shell morphometry compared to scallops without encrustation. However, C. hastatadid exhibit scaling relationships associated with maximizing swimming efficiency. Specifically, shell width and adductor muscle mass were positively allometric with shell height, while shell mass was negatively allometric with shell height. Scallops increased their energy expenditure (both aerobic and anaerobic) during valve-clapping, but no significant difference was detected between unencrusted (43·0 μmol adenosine triphosphate [ATP] consumed during a two min escape swim) and sponge-encrusted (40·0 μmol ATP) scallops. Scallops in both treatments derived 86% of the energy used for swimming from anaerobic sources. The lack of substantial differences between scallops with and without commensal sponges is partially explained by the observation that even heavy sponge encrustation increases the immersed weight of the scallop by only 5%. The presence of a sponge encrustation does not appear to inhibit swimming by this scallop species

Trial Protocol: Randomised controlled trial of the effects of very low calorie diet, modest dietary restriction, and sequential behavioural programme on hunger, urges to smoke, abstinence and weight gain in overweight smokers stopping smoking

Background\ud Weight gain accompanies smoking cessation, but dieting during quitting is controversial as hunger may increase urges to smoke. This is a feasibility trial for the investigation of a very low calorie diet (VLCD), individual modest energy restriction, and usual advice on hunger, ketosis, urges to smoke, abstinence and weight gain in overweight smokers trying to quit. \ud \ud Methods\ud This is a 3 armed, unblinded, randomized controlled trial in overweight (BMI > 25 kg/$m^2$), daily smokers (CO > 10 ppm); with at least 30 participants in each group. Each group receives identical behavioural support and NRT patches (25 mg(8 weeks),15 mg(2 weeks),10 mg(2 weeks)). The VLCD group receive a 429-559 kcal/day liquid formula beginning 1 week before quitting and continuing for 4 weeks afterwards. The modest energy restricted group (termed individual dietary and activity planning(IDAP)) engage in goal-setting and receive an energy prescription based on individual basal metabolic rate(BMR) aiming for daily reduction of 600 kcal. The control group receive usual dietary advice that accompanies smoking cessation i.e. avoiding feeling hungry but eating healthy snacks. After this, the VLCD participants receive IDAP to provide support for changing eating habits in the longer term; the IDAP group continues receiving this support. The control group receive IDAP 8 weeks after quitting. This allows us to compare IDAP following a successful quit attempt with dieting concurrently during quitting. It also aims to prevent attrition in the unblinded, control group by meeting their need for weight management. Follow-up occurs at 6 and 12 months. \ud \ud Outcome measures include participant acceptability, measured qualitatively by semi-structured interviewing and quantitatively by recruitment and attrition rates. Feasibility of running the trial within primary care is measured by interview and questionnaire of the treatment providers. Adherence to the VLCD is verified by the presence of urinary ketones measured weekly. Daily urges to smoke, hunger and withdrawal are measured using the Mood and Physical Symptoms Scale-Combined (MPSS-C) and a Hunger Craving Score (HCS). 24 hour, 7 day point prevalence and 4-week prolonged abstinence (Russell Standard) is confirmed by CO < 10 ppm. Weight, waist and hip circumference and percentage body fat are measured at each visit. \ud \ud Trial Registration\ud Current controlled trials ISRCTN83865809\ud \u

A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection

Nipah virus is a broadly tropic and highly pathogenic zoonotic paramyxovirus in the genus Henipavirus whose natural reservoirs are several species of Pteropus fruit bats. Nipah virus has repeatedly caused outbreaks over the past decade associated with a severe and often fatal disease in humans and animals. Here, a new ferret model of Nipah virus pathogenesis is described where both respiratory and neurological disease are present in infected animals. Severe disease occurs with viral doses as low as 500 TCID50 within 6 to 10 days following infection. The underlying pathology seen in the ferret closely resembles that seen in Nipah virus infected humans, characterized as a widespread multisystemic vasculitis, with virus replicating in highly vascular tissues including lung, spleen and brain, with recoverable virus from a variety of tissues. Using this ferret model a cross-reactive neutralizing human monoclonal antibody, m102.4, targeting the henipavirus G glycoprotein was evaluated in vivo as a potential therapeutic agent. All ferrets that received m102.4 ten hours following a high dose oral-nasal Nipah virus challenge were protected from disease while all controls died. This study is the first successful post-exposure passive antibody therapy for Nipah virus using a human monoclonal antibody

Medical Safety and Device Reliability of Active Transcutaneous Middle Ear and Bone Conducting Implants: A Long-Term Multi-Centre Observational Study

Active bone-conducting hearing devices (aBCHD; e.g., MEDEL Bonebridge® (BB)) and active middle ear implants (aMEI; e.g., MEDEL Vibrant Soundbridge® (VSB)) use radio frequency transmission to send information from an external microphone and sound processor to an internally implanted transducer. These devices potentially have an advantage over devices with percutaneous links because the skin is closed over the implantable components, which should reduce the risk of skin problems and infection. On the other hand, surgical procedures are more complex, with a greater risk of damage due to surgery. The objectives of this research were to quantify the reliability and long-term survival of MEDEL VSB and BB devices, determine the adverse and serious adverse device-related complications, and consider associated causes. A multi-center observational retrospective and prospective study was conducted at eleven auditory implant centers in the United Kingdom. Data was collected using a surgical questionnaire and audiological reports. Data were obtained from patient notes or from prospective cases that had a minimum follow-up of one year post-implant. Consecutive patient records were reviewed. Datasets from 109 BB and 163 VSB were reviewed. Of these, 205 were retrospective case note reviews, and 67 were prospective cases. The mean follow-up was 4 and 6 years, respectively, for BB and VSB. Kaplan–Meier Survival analyses indicated that the BB survival was 97% and 93.3% at 1 and 5 years, respectively, and the VSB was 92.1% and 87% at the same time points. This is a large cohort study for the field and has indicated that BB and VSB are safe interventions. Care should be taken to monitor magnet strength in the first few months. For the majority of device-related effects, there was no apparent association with etiology. However, an interesting pattern emerged for individuals who exhibited an inflammatory response, e.g., adhesions or device extrusion, and those with a history of chronic suppurative otitis media. This should be considered in future work and is not surprising given that many VSB recipients have a complicated hearing history, often associated with otitis media

Evaluating the effectiveness and reliability of the Vibrant Soundbridge and Bonebridge auditory implants in clinical practice: Study design and methods for a multi-centre longitudinal observational study.

BACKGROUND: The Vibrant Soundbridge middle ear implant and the Bonebridge bone conducting hearing device are hearing implants that use radio frequency transmission to send information from the sound processor to the internal transducer. This reduces the risk of skin problems and infection but requires a more involved surgical procedure than competitor skin penetrating devices. It is not known whether more complex surgery will lead to additional complications. There is little information available on the reliability of these systems and adverse medical or surgical events. The primary research question is to determine the reliability and complication rate for the Vibrant Soundbridge and Bonebridge. The secondary research question explores changes in quality of life following implantation of the devices. The tertiary research question looks at effectiveness via changes in auditory performance. METHOD: The study was designed based on a combination of a literature search, two clinician focus groups and expert review.A multi-centre longitudinal observational study was designed. There are three study groups, two will have been implanted prior to the start of the study and one group, the prospective group, will be implanted after initiation of the study. Outcomes are surgical questionnaires, measures of quality of life, user satisfaction and speech perception tests in quiet and in noise. CONCLUSION: This is the first multi-centre study to look at these interventions and includes follow up over time to understand effectiveness, reliability, quality of life and complications